Autopsy specimens of MS patients show the upregulation of Nrf2 and the Nrf2-responsive genes HO-1 and NQO-1, in and near to the active lesions in spinal cord and brain samples [55,56], as an integral part of the cellular anti-oxidative response. Here, NFE2L2 is linked to myeloid sarcoma.